Options
Alexander Geissler
Title
Prof. Dr.
Last Name
Geissler
First name
Alexander
Email
alexander.geissler@unisg.ch
ORCID
Phone
+41 71 224 30 17
Homepage
Google Scholar
Now showing
1 - 3 of 3
-
PublicationIdentifikation und Quantifizierung von Low Value Care mit anonymisierten Schweizer Versichertendaten am Beispiel von chronisch-obstruktiver Lungenerkrankung (COPD) und koronarer Herzkrankheit (KHK)(Lehrstuhl Management im Gesundheitswesen, School of Medicine, Universität St.Gallen, 2023)Type: working paperJournal: Schriftenreihe in Health Economics, Management and PolicyIssue: 2023-01
-
PublicationInstrument zur Evaluierung des Reifegrades der Krankenhäuser hinsichtlich der Digitalisierung(Lehrstuhl Management im Gesundheitswesen, School of Medicine, Universität St.Gallen, 2021)
;DigitalRadar Krankenhaus, KonsortiumType: working paperJournal: Schriftenreihe in Health Economics, Management and PolicyIssue: 01 -
PublicationDigitalization in MedTech: Understanding the Impact on Total Knee Arthroplasty(Chair of Healthcare Management, School of Medicine, University of St.Gallen, 2021)
;Lorenz, Max ;Reinhard, Patrick ;Spring, ThomasDigital Technologies (DTs) in healthcare are of growing relevance for different actors along the patient journey. This paper breaks down the complex landscape of digitalization by focusing on the Total Knee Arthroplasty (TKA). It aims to identify today's technologies and the most promising future trend, assessing the impact on the respective stakeholders. To answer these questions, a structured literature review (SLR) was conducted combining the search term digital AND knee AND replacement with journey OR value OR trend. This resulted in 39 peer-reviewed articles for in-depth analysis. In addition, a qualitative assessment was carried out based on 27 semi-structured interviews (SSI) with six stakeholder groups (patients, surgeons, physiotherapists, industry experts, insurance representatives, regulators) along the patients' TKA journey. The SLR revealed five clusters (3D Printing, Big Data, Wearables, Virtual Healthcare, Robotics) as most recurrent DTs within TKA. The SSIs confirmed that all five clusters are relevant and recognised today. Big Data is considered by the stakeholders to be the most promising DT in the future because of its power to interconnect the other technologies and thereby improve health outcomes. Among the different stakeholder groups, the effect of DTs on their individual roles were perceived differently. Regulatory hurdles and cost-benefit uncertainties were determined to be the most prominent obstacles on the establishment of DTs. Improvements in patient outcomes is the principal gain from utilizing DTs throughout the patient journey. However, the benefits of switching to DTs require convincing scientific evidence to promote acceptance by all stakeholders in a value-based healthcare system.Type: working paperIssue: 02